Cargando…

Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice

The cannabis constituent cannabidiol (CBD) possesses anxiolytic and antipsychotic properties. We have previously shown that transmembrane domain neuregulin 1 mutant (Nrg1 TM HET) mice display altered neurobehavioural responses to the main psychoactive constituent of cannabis, Δ(9)-tetrahydrocannabin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Leonora E., Chesworth, Rose, Huang, Xu-Feng, Wong, Alexander, Spiro, Adena, McGregor, Iain S., Arnold, Jonathon C., Karl, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/ https://www.ncbi.nlm.nih.gov/pubmed/22509273 http://dx.doi.org/10.1371/journal.pone.0034129

Ejemplares similares

The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice
por: Chesworth, Rose, et al.
Publicado: (2018)

Neuregulin 1 Expression and Electrophysiological Abnormalities in the Neuregulin 1 Transmembrane Domain Heterozygous Mutant Mouse
por: Long, Leonora E., et al.
Publicado: (2015)

T177. CANNABIDIOL AS A POTENTIAL PREVENTATIVE TREATMENT IN A NEUREGULIN-1 MOUSE MODEL OF SCHIZOPHRENIA
por: Visini, Gabriela, et al.
Publicado: (2020)

The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
por: Visini, Gabriela, et al.
Publicado: (2022)

M91. ADDICTION-RELEVANT BEHAVIOURS FOR COCAINE IN A NEUREGULIN 1 MUTANT MOUSE MODEL OF SCHIZOPHRENIA
por: Chesworth, Rose, et al.
Publicado: (2020)

Adolescent Oxytocin Exposure Causes Persistent Reductions in Anxiety and Alcohol Consumption and Enhances Sociability in Rats
por: Bowen, Michael T., et al.
Publicado: (2011)

Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits
por: Pei, Ju-Chun, et al.
Publicado: (2014)

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
por: Arnold, Jonathon C., et al.
Publicado: (2022)

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
por: Umpierrez, Laísa S., et al.
Publicado: (2022)

Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model
por: Chesworth, Rose, et al.
Publicado: (2022)

What does a mouse tell us about neuregulin 1—cannabis interactions?
por: Karl, Tim, et al.
Publicado: (2013)

ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
por: Brzozowska, Natalia, et al.
Publicado: (2016)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Enhanced Brain Disposition and Effects of Δ(9)-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice
por: Spiro, Adena S., et al.
Publicado: (2012)

Human Immunodeficiency Virus-Associated Neurobehavioural Disorder
por: Grant, Igor, et al.
Publicado: (1988)

Identifying genes for neurobehavioural traits in rodents: progress and pitfalls
por: Baud, Amelie, et al.
Publicado: (2017)

Editorial: Neurobehavioural Mechanisms of Resilience and Vulnerability in Addictive Disorders
por: Aguilar, Maria A., et al.
Publicado: (2021)

Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
por: McCartney, Danielle, et al.
Publicado: (2020)

Prescribing medicinal cannabis
por: Arnold, Jonathon C, et al.
Publicado: (2020)

Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants
por: Gorman, Paul M, et al.
Publicado: (2008)

Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2017)

Impact of gasoline inhalation on some neurobehavioural characteristics of male rats
por: Kinawy, Amal A
Publicado: (2009)

Neurobehavioural signatures in race car driving: a case study
por: Rito Lima, Ines, et al.
Publicado: (2020)

Quantitative behavioural phenotyping to investigate anaesthesia induced neurobehavioural impairment
por: Nambyiah, Pratheeban, et al.
Publicado: (2021)

Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice
por: Spencer, Jarrah R., et al.
Publicado: (2013)

Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus
por: Zhang, Lei, et al.
Publicado: (2021)

Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype
por: Smith, Katherine M, et al.
Publicado: (2011)

When Clocks Go Bad: Neurobehavioural Consequences of Disrupted Circadian Timing
por: Barnard, Alun R., et al.
Publicado: (2008)

The relationship between ventricular dilatation, neuropathological and neurobehavioural changes in hydrocephalic rats
por: Olopade, Funmilayo Eniola, et al.
Publicado: (2012)

Continuum of neurobehaviour and its associations with brain MRI in infants born preterm
por: Eeles, Abbey L, et al.
Publicado: (2017)

Exploring Neurobehaviour in Zebrafish Embryos as a Screening Model for Addictiveness of Substances
por: Havermans, Anne, et al.
Publicado: (2021)

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
por: McCartney, Danielle, et al.
Publicado: (2022)

Neuregulins in Neurodegenerative Diseases
por: Ou, Guan-yong, et al.
Publicado: (2021)

Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
por: Suraev, Anastasia, et al.
Publicado: (2020)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

A cataract-causing connexin 50 mutant is mislocalized to the ER due to loss of the fourth transmembrane domain and cytoplasmic domain()
por: Somaraju Chalasani, Madhavi Latha, et al.
Publicado: (2012)

Impact of the Neuregulin rs35753505 C/T Polymorphisms on Neuregulin 1 Levels in Preterm Infants
por: Lubis, Bugis Mardina, et al.
Publicado: (2019)

The clinical and cost-benefits of investing in neurobehavioural rehabilitation: A multi-centre study
por: Oddy, Michael, et al.
Publicado: (2013)

Understanding Neurobehavioural Dynamics: A Close-Up View on Psychiatry and Quantum Mechanics
por: Latif, Wani Ab, et al.
Publicado: (2019)

Cuprizone toxicity and Garcinia kola biflavonoid complex activity on hippocampal morphology and neurobehaviour
por: Omotoso, G.O., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1og5nvst71shi5clgf5g6ag7r8